Category Archives: Cardiovascular

Heart health: How much vitamin D do we really need?

Share on PinterestHave official guidelines for vitamin D intake missed the mark when it comes to heart health? Image credit: Zorica Nastasic/Getty Images. Vitamin D is an essential nutrient, and researchers are interested in how it may help in several health areas. One area of interest is how much vitamin D supplementation is required to […]

Global Registries And Surveys Programme of the ESC

GRASP is a programme of observational, multicenter, international, prospective and retrospective, longitudinal and cross-sectional studies with the aim to capture real world evidence. The main objectives of GRASP are: To evaluate the implementation of ESC Clinical Practice Guidelines, aiming to close the gap between guideline standards and clinical practice, and to identify gaps in adherence […]

Can Depression Treatment Reduce Cardiovascular Risks?

A new study published in the Journal of Brain, Behavior, and Immunity looked at the effect of modernized collaborative care for depression on depressive symptoms and cardiovascular disease risk biomarkers. “We set out to determine whether treating depression, a psychological risk factor for cardiovascular disease (CVD), could reduce the risk of developing CVD in the […]

Exploring Patients’ Perspectives on OHI: A Qualitative Study among Those with High Cardiovascular Risk

The following is a summary of “How do patients with high cardiovascular risk evaluate online health information? A qualitative study,” published in the November 2023 issue of Primary Care by Lim, et al. The proliferation of online health information (OHI) challenges individuals in discerning between reliable and unreliable sources. For a qualitative study, researchers sought […]

Trial to prevent sudden death after a heart attack enrols first patient

Sophia Antipolis – 21 November 2023:  The first clinical trial to challenge the routine implantation of a defibrillator in myocardial infarction survivors with heart failure has enrolled its first patient. The PROFID EHRA trial is part of the EU-funded PROFID project, which aims to personalise the prevention of sudden cardiac death after myocardial infarction and […]

Stroke and Cardiovascular disease are leading causes of death, according

…WINTER WEATHER ADVISORY REMAINS IN EFFECT FROM 9 AM THIS MORNING TO 3 PM EST THIS AFTERNOON… * WHAT…Mixed precipitation expected. Ice accumulations of around one tenth of an inch on the highest elevations, little to no ice in the valleys. Snow and sleet accumulations less than an inch. Winds gusting as high as 40 […]

Decoding the Future of Cardiovascular Health: Navigating the Road Ahead with Genomics and Polygenic Risk Scores

by Dr Firoz Ahmad Cardiovascular diseases (CVD) as a result of coronary artery diseases (CAD) are a group of health issues that affect the heart and the blood vessels which are essential for optimal heart functioning. It is a leading cause of death worldwide, particularly in India, where it accounts for roughly two-thirds of all […]

Patients with OSA, COPD frequently have cardiovascular disease

November 21, 2023 3 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . <button type="button" class="btn btn-primary" data-loading-text="Loading ” data-action=”subscribe”> Subscribe Added to email alerts We were unable to process your request. […]

New Study Examines the Role of Ferroptosis in Heart Disease

Heart disease is a leading cause of death in the United States. The Centers for Disease Control and Prevention cite one American dies every 33 seconds because of cardiovascular disease.1 Due to the staggering numbers, heart dysfunction is a well-researched subject. Every finding brings new knowledge to the surface — and one recently led to […]

OCEANIC-AF Trial Sunk; Second Renal Denervation Device Approved; Strep-Stroke Link?

Bayer announced that the phase III OCEANIC-AF study of the oral factor XIa inhibitor asundexian was stopped early due to inferior efficacy compared with apixaban (Eliquis) for patients with atrial fibrillation (Afib). The CDC reported that the age-adjusted prevalence of hypertension climbed to 44.2% in Los Angeles County and 47.3% across the U.S. from 2015 […]